Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Stemco Biomedical
AddedFeb 15, 2024
UpdatedJun 18, 2026
Stemco Biomedical

Stemco Biomedical

Inactive

StemCo Biomedical: Innovating in stem cell transplantation with custom-engineered grafts for improved therapy.

HQ
Durham, NC, US
Founded
1999
Overview
Compare
Fundraising
Employees

StemCo Biomedical, founded in 1999 in Research Triangle Park, NC, focuses on developing, manufacturing, and distributing medical products to enhance therapeutic transplantation of adult hematopoietic stem and progenitor cells from bone marrow, peripheral blood, or umbilical cord blood. The company targets a market exceeding $1 billion annually with its innovative solutions.

StemCo Biomedical has achieved significant milestones in the stem cell transplantation field, offering custom-engineered grafts that improve therapy outcomes. Their products have been instrumental in advancing medical treatments and have made a notable impact on the healthcare industry.

Stemco Biomedical - Similar Companies

Stemcyte logo

Stemcyte

stemcyte.com

Stemedica Cell Technologies logo

Stemedica Cell Technologies

stemedica.com

StemBioSys logo

StemBioSys

stembiosys.com

Stemtech logo

Stemtech

stemtech.com

Stemgenics logo

Stemgenics

stemgenics.com

StemSave logo

StemSave

stemsave.com

U.S. Stem Cell logo

U.S. Stem Cell

us-stemcell.com

Personalized Stem Cells logo

Personalized Stem Cells

RhinoCyte logo

RhinoCyte

rhinocyte.com

AlphaStem logo

AlphaStem

alpha-stim.com

Stemson Therapeutics logo

Stemson Therapeutics

stemsontx.com

MitoStem logo

MitoStem

Commence Bio logo

Commence Bio

ImStem Biotechnology logo

ImStem Biotechnology

imstem.com

APstem Therapeutics logo

APstem Therapeutics

apstemtx.com

Stemco Biomedical - Quick Facts

Who are Stemco Biomedical's competitors?

Companies similar to Stemco Biomedical include Stemcyte, Stemedica Cell Technologies, StemBioSys and Stemtech.

When was Stemco Biomedical founded?

Stemco Biomedical was founded in 1999.

Where is Stemco Biomedical's headquarters located?

Stemco Biomedical's headquarters is located in Durham, NC, US.

When was Stemco Biomedical's last funding round?

Stemco Biomedical's most recent funding round was for $9.8M (USD) in March 2003.

How much has Stemco Biomedical raised to-date?

As of Mar 18, 2003, Stemco Biomedical has raised a total of $13.8M (USD).

Stemco Biomedical - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • Medical Products
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 9 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research